These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10352443)

  • 1. Muscle fiber-type changes induced by botulinum toxin injection in the rat larynx.
    Inagi K; Connor NP; Schultz E; Ford CN; Cook CH; Heisey DM
    Otolaryngol Head Neck Surg; 1999 Jun; 120(6):876-83. PubMed ID: 10352443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic assessment of botulinum toxin effects in the rat larynx.
    Inagi K; Connor NP; Ford CN; Schultz E; Rodriquez AA; Bless DM; Pasic T; Heisey DM
    Laryngoscope; 1998 Jul; 108(7):1048-54. PubMed ID: 9665255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased acute and chronic mitotic activity in rat laryngeal muscles after botulinum toxin injection.
    Inagi K; Connor NP; Schultz E; Ford CN; Cook CH; Bless DM; Heisey DM
    Laryngoscope; 1998 Jul; 108(7):1055-61. PubMed ID: 9665256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
    Inagi K; Rodriquez AA; Ford CN; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of fiber types determined by in situ hybridization of myosin heavy chain mRNA and enzyme histochemistry in rat skeletal muscles.
    Kanbara K; Sakai A; Watanabe M; Furuya E; Shimada M
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):319-27. PubMed ID: 9193786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic changes in rat thyroarytenoid muscle induced by botulinum neurotoxin injection.
    Welham NV; Marriott G; Tateya I; Bless DM
    Proteomics; 2008 May; 8(9):1933-44. PubMed ID: 18442174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
    J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1995 Feb; 24(1):64-8. PubMed ID: 7769649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical myosin heavy chain in rat laryngeal muscle.
    DelGaudio JM; Sciote JJ; Carroll WR; Escalmado RM
    Ann Otol Rhinol Laryngol; 1995 Mar; 104(3):237-45. PubMed ID: 7872608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular partitioning, architectural design, and myosin fiber types of the M. vastus lateralis of the llama (Lama glama).
    Graziotti GH; Palencia P; Delhon G; Rivero JL
    J Morphol; 2004 Nov; 262(2):667-81. PubMed ID: 15376272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients.
    Rosow DE; Pechman A; Saint-Victor S; Lo K; Lundy DS; Casiano RR
    J Voice; 2015 May; 29(3):352-5. PubMed ID: 25242042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
    Ludlow CL; Naunton RF; Terada S; Anderson BJ
    Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasticity of denervated and reinnervated laryngeal muscle: focus on single-fiber myosin heavy-chain isoform expression.
    Wu YZ; Baker MJ; Marie JP; Crumley R; Caiozzo VJ
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1070-82. PubMed ID: 15381594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
    Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE
    J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.
    Rosales RL; Arimura K; Takenaga S; Osame M
    Muscle Nerve; 1996 Apr; 19(4):488-96. PubMed ID: 8622728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for three fast myosin heavy chain isoforms in type II skeletal muscle fibers in the adult llama (Lama glama).
    Graziotti GH; Ríos CM; Rivero JL
    J Histochem Cytochem; 2001 Aug; 49(8):1033-44. PubMed ID: 11457931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia.
    Damrose JF; Goldman SN; Groessl EJ; Orloff LA
    J Voice; 2004 Sep; 18(3):415-22. PubMed ID: 15331116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.
    Shaari CM; Sanders I
    Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.